CLINUVEL PHARMACEUT. short interest in 2026

In 2026, CLINUVEL PHARMACEUT.'s disclosed short interest ran from 6.59% of units on issue on 2 Jan 2026 to 9.07% on 7 Oct 2026, a change of +2.48 percentage points. The year's high was 9.54% on 7 Jan 2026 and its low 5.12% on 11 Mar 2026, averaging 8.40% across 195 trading days. Full history: CLINUVEL PHARMACEUT..

Cite this page

Plain

Short position data for CLINUVEL PHARMACEUT. short interest in 2026: ASIC, compiled by howshorted.com, trade date 7 Oct 2026. https://howshorted.com/au/company/cuv/2026/

Wikipedia

<ref>{{cite web |title=CLINUVEL PHARMACEUT. short interest in 2026 short position data |url=https://howshorted.com/au/company/cuv/2026/ |website=HowShorted |publisher=howshorted.com (data: ASIC) |date=2026-10-07 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-clinuvel-pharmaceut-short-interest-in-20-2026-10-07,
  title        = {CLINUVEL PHARMACEUT. short interest in 2026 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/au/company/cuv/2026/}},
  note         = {Data: ASIC, trade date 7 Oct 2026; accessed 2026-10-13},
  year         = {2026}
}

By year: 2010 · 2011 · 2012 · 2014 · 2015 · 2016 · 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

2026 in figures

Start of year: 6.59% (2 Jan 2026)
End of year: 9.07% (7 Oct 2026)
Change: +2.48 pp
High: 9.54% (7 Jan 2026)
Low: 5.12% (11 Mar 2026)
Average: 8.40%

Month by month in 2026

CLINUVEL PHARMACEUT. short interest in 2026
Month	Month end	Month high	Trade dates
January	7.13%	9.54% (7 Jan 2026)	20
February	7.49%	7.49% (27 Feb 2026)	20
March	8.36%	8.36% (30 Mar 2026)	22
April	8.90%	8.90% (30 Apr 2026)	20
May	9.38%	9.38% (29 May 2026)	21
June	9.28%	9.48% (22 Jun 2026)	21
July	8.82%	9.25% (1 Jul 2026)	23
August	8.35%	8.79% (4 Aug 2026)	21
September	8.97%	9.06% (25 Sep 2026)	22
October	9.07%	9.07% (5 Oct 2026)	5

About this data

Figures are disclosed positions as published by the ASIC; positions below the disclosure threshold are not public, so published figures are a floor. Not affiliated with the ASIC. Nothing here is investment advice. Method: methodology.